Aju IB Investment — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Neuroxtneuroxt.co.krJun 2022

NeuroXT develops MRI-based AI software that predicts amyloid and tau burden to guide Alzheimer's disease treatment decisions.

Co-investorsDAYLI Partners Kakao Ventures Smilegate Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.